AIWall Street Journal1h ago
Pharmaceutical leaders are skeptical of claims
Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs
TL;DRAI hasn't actually produced an FDA-approved drug yet; pharma execs doubt the hype.
Why it matters: Separates real AI progress in biotech from marketing claims before betting on the sector.
No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle
Read full articleSource: Wall Street Journal · Opens in new tab